Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stellate Gnaglion Block Versus Conventional Therapey in Refractory Bell's Palsy; A Rondomized Single Blind Clinical Trial

NCT05094245 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT05094245
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05094245 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stellate Gnaglion Block Versus Conventional Therapey in Refractory Bell's Palsy; A Rondomized Single Blind Clinical Trial
Lead sponsor
Assiut University
Phase
Not applicable
Overall status
Completed
Start date
November 1, 2021
Completion date
June 30, 2022
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

facial palsy, neuropathy